학술논문
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.
Document Type
Article
Author
Haddad, Robert I.; Harrington, Kevin; Tahara, Makoto; Ferris, Robert L.; Gillison, Maura; Fayette, Jerome; Daste, Amaury; Koralewski, Piotr; Zurawski, Bogdan; Taberna, Miren; Saba, Nabil F.; Mak, Milena; Kawecki, Andrzej; Girotto, Gustavo; Alvarez Avitia, Miguel Angel; Even, Caroline; Toledo, Joaquin Gabriel Reinoso; Guminski, Alexander; Müller-Richter, Urs; Kiyota, Naomi
Source
Journal of Clinical Oncology; 4/20/2023, Vol. 41 Issue 12, p2166-2180, 15p
Subject
Language
ISSN
0732183X